SCIENTIFIC METHOD
Reliability of knowledge, ifwe accept H.A.F. Dudley's view, stretches along a continuum from ignorance at the far left to certainty at the far right (1) . Rigorous scientific and research methods, using various forms of measurement as a cardinal procedure, serve to distinguish mere appearances from reality; to ascertain the actual relationships between phenomena; and to counter the tendency to rely uncritically on initial observations or to mistake a mere semblance of correlation for a judgme~t o~fact. 
ADVANCES AND CHALLENGES
Spectacular advances in the basic sciences throughout this century have dramatically increased the explanatory power of medicine, the ability to accurately identify and understand the causes and the physiological, cellular, and genetic mechanisms of disease. Yet challenges still abound. The notable basic explanatory challenge in cancer science centers on need for a comprehensive and fundamental understanding of the biological heterogeneity of primary cancers and metastases, and of the metastatic process (2) . In research designed to perfect the treatment and management of patients, randomized clinical trials have greatly increased the validity and generalizability of evaluative studies (3) .
Yet, there remains a basic problem and challenge. Humanly costly and resource-intensive randomized clinical trial-results are often clinically implemented in only very limited ways. The problem is not limited to the admitted need to transhue the results of clinical trials into practice more effectively, nor is the problem solvable by technique alone or by more careful blueprinting of randomization designs. Randomization, whatever its contribution, is not the root of the basic problem of scientific adequacy. A basic problem of scientific adequacy in clinical research, if A.
Feinstein is correct, is the frequent absence from management studies of precise and scientifically cogent human information derived directly from the patient. The symptoms and personal problems of patients are often ignored or disdained or inadequately characterized and measured because the information is not regarded as hard enough, reliable enough, or worthy ofscientific attention (4) .
PAYING ATIENTION SCIENTIFICALLY TO SICK PEOPLE
The basic problem of scientific adequacy in clinical research, mentioned above, is linked to a perception or assumption that rea/science is done in the explanatory mode, that the laboratory, not the bedside, is the environment for real experimentation, and that the activities of ordinary clinical practice, specifically the observation of clinical events under natural conditions, are not amenable to scientific method. This intellectual bias disfavors development ofa scientific plan for routine clinical activities (5) .
Basic data for explanatory and clinical studies have to come from those who work in the field. The field here is the bedside and clinicians who spend their time riveted in attention to the bodies and minds ofsick people are those best placed to observe, describe, measure, and categorize the crucial human data. This is altogether too often overlooked in the evaluation ofcurative and palliative treatments.
Clinicians are best placed to master these data, but the need is to heighten the scientific quality of clinical attention to the variety and subtle differences in patients' symptoms, pain, and responses to treatment. Soft data can be hardened, made more reliable, and brought into the sphere of more traditional scientific work to the extent that clinicians. improve their techniques of clinical observation, develop scales and rating systems to reduce observer variability, and define criteria that can assure consistency in clinical observations (6) .
The authors .of the first contribution to the Journal's new section, From the Literature, remind us that palliative medicine deals with subjective and objective events and-that many of these are difficult to assess, to document, and to interpret. The authors also imply that innovative ways are needed to pay closer scientific attention to these realities, innovative ways that are different from and complementary to traditional clinical science (7) .
